Abstract
In reviewing the above article [Ait-Oudhia S, Straubinger RM, and Mager DE (2013) J Pharmacol Exp Ther 344(1): 103-112; DOI: https://doi.org/10.1124/jpet.112.199109], the authors discovered panels A and E in Figure 2 are incorrect, along with typos in several parameters (mostly units) in Table 2. The modeling and simulations have been faithfully reproduced, and these errors do not change the results and conclusions of the paper. The correct versions of Table 2 and Figure 2 appear below and in the PDF and HTML versions of this article. The authors apologize for any inconvenience caused by these errors. (Table Presented).
| Original language | English |
|---|---|
| Pages (from-to) | 365-366 |
| Number of pages | 2 |
| Journal | Journal of Pharmacology and Experimental Therapeutics |
| Volume | 366 |
| Issue number | 2 |
| DOIs |
|
| State | Published - Aug 2018 |
Fingerprint
Dive into the research topics of 'Correction: Systems pharmacological analysis of paclitaxel-mediated tumor priming that enhances nanocarrier deposition and efficacy (Journal of Pharmacology and Experimental Therapeutics (2013) 344: 1 (103-112) DOI: 10.1124/jpet.112.199109)'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver